Syndax Pharmaceuticals Inc (SNDX) — Capital Reinvestment Ratio
Latest as of December 2021:
0.00x
Syndax Pharmaceuticals Inc (SNDX) has a Capital Reinvestment Ratio of 0.00x as of December 2021, meaning it reinvests 0% of its operating cash flow ($100.71 Million) in capital expenditures ($129.00K). See SNDX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$100.71 Million
USD
Capital Expenditures
$129.00K
USD
Data as of
Dec 2021
Most recent filing
Syndax Pharmaceuticals Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Syndax Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Syndax Pharmaceuticals Inc from 2021 to 2021. For live market cap and broader valuation context, see Syndax Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $29.13 Million | $129.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow